NCTId,BriefTitle,OverallStatus,StudyType,Phases,Conditions,LeadSponsorName,StartDate,StudyFirstPostDate,LastUpdatePostDate,Timestamp
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-11-03T07:17:42.252370
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-11-03T07:17:42.252370
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-11-03T07:17:42.252370
